Gingivitis

Gingivitis is inflammation of the gingiva (gum tissue) triggered by bacterial biofilm — dental plaque — accumulating at and just below the gumline. Bacterial byproducts in the plaque provoke a local host inflammatory response: the gingival blood vessels dilate and become more permeable, producing the redness, swelling, and easy bleeding that define the condition.^[1] If plaque is not disrupted daily by brushing and flossing, it mineralizes into tartar (calculus) within days, which only professional instrumentation can remove and which itself becomes a further plaque-retentive, inflammation-perpetuating surface.^[1][2]

Gingivitis is the earliest and mildest stage of periodontal disease — and the only stage that is genuinely reversible. By definition it involves inflammation confined to the gingiva, with no loss of the connective-tissue attachment or supporting bone that anchors the tooth. The internationally adopted 2018 AAP/EFP classification of periodontal diseases formalizes this: gingival health is bleeding on probing at <10% of sites, gingivitis is bleeding on probing at 10% of sites or more (subdivided into localized, 10-30% of sites, and generalized, over 30%), and both categories require a probing depth no greater than 3 mm with no attachment loss. Periodontitis, by contrast, is defined by measurable attachment loss and is not reversible in the same way — a distinction developed fully in Recognize the Condition, because it determines whether a case belongs in a pharmacy consult at all.^[3]

Plaque and calculus accumulation along the gumline with the erythema and gingival swelling typical of gingivitis. (Roquex, CC0 1.0 Public Domain, Wikimedia Commons)

Gingivitis is extremely common. The Canadian Dental Association states that 7 out of 10 Canadians will develop gum disease at some point in their lives, making it the most common dental problem seen in practice.^[2] The American Dental Association similarly describes gingivitis as very common, including among children, and notes that at this stage "the disease is still reversible" with a professional cleaning plus daily brushing and flossing.^[4] Left untreated, gingivitis can — though does not always — progress to periodontitis, at which point the disease is no longer confined to reversible soft-tissue inflammation and is far more prevalent than most patients realize: the ADA reports that chronic periodontitis affects 47.2% of American adults over age 30.^[5] This progression risk, not the gingivitis itself, is what makes early recognition and genuinely effective counselling worthwhile.^[1][3]

What patients report

Patients typically notice blood on their toothbrush or in the sink after brushing, gums that look redder or puffier than usual, or mild tenderness — but importantly, gingivitis is usually painless, which is precisely why it is so often ignored until a dental visit or a pharmacist raises it.^[1][4] Some patients report bad breath, though persistent halitosis despite good hygiene is more suggestive of periodontitis and is covered in Red Flags and Referral.

What you find on examination

Look for gingival erythema (redness) and edema (swelling), loss of the normal stippled ("orange-peel") texture of healthy gingiva, rounded or bulbous rather than knife-edged interdental papillae, and bleeding on gentle probing or brushing. Healthy gingiva is firm, pale pink (allowing for normal physiologic pigmentation), and does not bleed with routine brushing.^[1][3] Visible plaque and supragingival calculus at the gumline are common accompanying findings and are themselves part of the diagnosis, not just a risk factor.^[2]

Differentiating gingivitis from periodontitis — the key clinical distinction

This is the single most important judgment call in this chapter, because it determines whether a case is appropriate for hygiene-focused counselling or needs referral for formal periodontal management. Gingivitis is inflammation without attachment loss or bone loss; periodontitis is inflammation with progressive, measurable loss of the connective-tissue attachment and supporting alveolar bone.^[3] Under the 2018 AAP/EFP classification, a periodontitis diagnosis specifically requires interproximal clinical attachment loss at two or more non-adjacent teeth, or buccal/lingual attachment loss of 3 mm or more with pocketing of 3 mm or more, at two or more teeth.^[3] A pharmacist cannot measure attachment loss or true periodontal pocket depth — that requires a dental periodontal probe and training — but the history and visible findings below reliably flag when a case is not simply gingivitis and needs that formal assessment.

^[3]

Why this distinction matters practically: recommending "just brush and floss more" to a patient who actually has undiagnosed periodontitis under-treats a progressive disease, while correctly identifying straightforward gingivitis lets a pharmacist give confident, genuinely effective self-care advice without over-referring every case of gum bleeding. See Red Flags and Referral for the specific findings that should prompt a periodontal referral rather than routine gingivitis counselling.

Poor oral hygiene — the primary driver

Inadequate or infrequent brushing and flossing is the dominant cause of gingivitis in almost every case: without daily mechanical disruption, plaque biofilm accumulates and matures into calculus, and the resulting bacterial load simply outpaces the gingiva's ability to stay uninflamed.^[1][2] Every other risk factor below acts by increasing bacterial burden, altering the host inflammatory response, or both — poor hygiene remains the common final pathway.

Smoking

Tobacco use is identified by the Canadian Dental Association as a major risk factor for gum disease and other dental complications, both by directly impairing gingival blood supply and healing and by promoting plaque accumulation.^[1] Practically important: nicotine-related vasoconstriction may reduce the visible bleeding on probing that pharmacists and dentists rely on as a warning sign, so smokers can have meaningfully inflamed gingiva with a deceptively unremarkable-looking exam — the mechanistic evidence for this specific vasoconstriction pathway in humans is not fully conclusive, but the clinical observation of masked bleeding in smokers is well described, and it argues for closer attention in smokers, not less.^[6]

Diabetes — a genuinely bidirectional relationship

Diabetes is one of only two factors (along with smoking) formally recognized as a true risk factor for periodontal disease in the 2018 AAP/EFP classification.^[7] The relationship runs both ways: poorly controlled diabetes worsens gingival and periodontal inflammation, and that inflammation in turn can worsen glycemic control — a genuinely bidirectional link that has been described in the literature for over 20 years.^[7] Diabetes now affects more than 8% of Canadians, a 37.3% increase in prevalence over the preceding decade according to Public Health Agency of Canada surveillance data, making this a common and clinically relevant intersection in everyday pharmacy practice.^[7] It is worth being precise with patients about the strength of this relationship: a 2021 Canadian Dental Hygienists Association position paper reviewing the highest-quality evidence found consistent but small reductions in HbA1c (averaging 0.26% to 0.65% across five systematic reviews/meta-analyses) at 3 months following non-surgical periodontal therapy, with the effect not clearly sustained at 6 months — real, but modest, and not a substitute for standard diabetes management.^[7] The clinically useful takeaway is the recommendation that patients with diabetes and any degree of periodontal inflammation have professional periodontal maintenance at intervals no longer than 3 months, rather than the standard 6-12 months.^[7]

Pregnancy — hormonal gingivitis

Pregnancy-associated (hormonal) gingivitis is a recognized and common entity, not a minor curiosity: gingivitis is reported to affect 60% to 75% of pregnant women, driven by fluctuating estrogen and progesterone levels acting together with changes in oral flora and a somewhat blunted local immune response.^[8] About half of women with pre-existing gingivitis experience a significant exacerbation during pregnancy.^[8] See Special Populations for management specifics.

Medications causing gingival hyperplasia — a genuinely pharmacist-relevant point

Three drug classes are well established causes of drug-induced gingival overgrowth (gingival hyperplasia), through a shared mechanism involving disturbed fibroblast calcium/folate handling that drives excess collagen deposition in the gingiva^[9]:

• Phenytoin (phenytoin) — the anticonvulsant prototype, with gingival overgrowth reported in up to 50% of patients on long-term therapy.^[9]
• Cyclosporine (cyclosporine) — the calcineurin-inhibitor immunosuppressant most often implicated, particularly common in solid-organ transplant recipients, with overgrowth reported in roughly 30% of patients.^[9]
• Calcium channel blockers, especially dihydropyridines such as nifedipine and amlodipine — reported in roughly 20% of patients on nifedipine, with amlodipine first documented to cause the same effect in 1994.^[9]

These three classes are not interchangeable in tissue appearance: phenytoin-induced overgrowth tends to be predominantly fibrotic, cyclosporine-induced overgrowth tends to be more inflamed with less fibrosis, and calcium-channel-blocker-induced overgrowth is typically a mixed picture — but for pharmacist purposes, the practical point is the same across all three: recognize the pattern, do not stop the drug unilaterally, and see Choose Initial Treatment and Special Populations for the actual management approach.^[9]

Xerostomia-causing medications — an indirect but real contributor

Saliva plays a genuine protective role against gingival inflammation, not only against caries: it buffers plaque acids, supplies antibacterial and antifungal proteins, and provides mechanical clearance of food debris and bacteria from the gumline.^[10] Medications that reduce salivary flow — anticholinergics, many antihistamines, tricyclic antidepressants, and others covered in this platform's Dry Mouth chapter — can therefore indirectly worsen gingival health by removing much of this protective effect, on top of whatever direct oral-hygiene barriers a patient may already face.^[10] A xerostomia complaint is a reasonable prompt to also ask about gingival bleeding, and vice versa.

History

Ask about the pattern and duration of bleeding (with brushing only, or also spontaneous), pain (gingivitis is typically painless — significant pain is itself a red flag), current brushing/flossing habits and frequency, time since the last professional dental cleaning, smoking status, pregnancy status, diabetes history and control, and a complete medication list with specific attention to phenytoin, cyclosporine, and calcium channel blockers.^[1][9]

Examination

Assess gingival colour, contour, and consistency, and look specifically for the findings described in Recognize the Condition: erythema, edema, loss of stippling, rounded papillae, and bleeding on gentle probing or brushing, together with visible plaque and calculus.^[1] Equally important is a targeted look for what should not be present in simple gingivitis: gum recession, visibly loose teeth, purulent discharge, or deep-looking pocketing — any of which shift the case toward Red Flags and Referral rather than routine counselling. A formal periodontal probing examination (measuring true attachment loss and pocket depth) is outside pharmacy scope and requires referral when the history or exam is ambiguous.^[3]

The Loe and Silness Gingival Index — a teaching reference, not a pharmacy diagnostic tool

Dental professionals commonly grade gingivitis severity using the Loe and Silness Gingival Index, reproduced here from the Health Canada-approved chlorhexidine gluconate 0.12% product monograph as a teaching reference for understanding how a dentist or hygienist is likely describing a patient's disease severity — it is not intended for pharmacists to score independently.^[12]

^[12]

When to pursue further assessment

Straightforward gingivitis with an obvious hygiene-related cause and none of the Red Flags and Referral findings does not need further workup — the "investigation" is the history and visual exam described above, and the treatment is the plan in Choose Initial Treatment. Pursue dental referral for a formal periodontal assessment whenever attachment loss, recession, mobility, pocketing, refractory halitosis, or a lack of response to good self-care after 2-4 weeks is present.^[3]

• Resolve gingival inflammation and restore healthy pink, firm, non-bleeding gingiva.
• Achieve this through consistent mechanical plaque removal, since gingivitis is fully reversible with adequate hygiene — the goal is genuine resolution, not just symptomatic improvement.
• Prevent progression to periodontitis, which is not reversible in the same way and requires lifelong periodontal maintenance once established.
• Identify and appropriately manage modifiable contributors — smoking, suboptimal glycemic control in diabetes, and a causative medication where one is present — rather than treating symptoms in isolation from their cause.
• Recognize and refer promptly any presentation that is not simple gingivitis: signs of periodontitis, necrotizing gingivitis, or severe medication-induced gingival hyperplasia.
• Use mouth rinses correctly, as adjuncts to mechanical plaque removal rather than substitutes for it, and set realistic expectations about duration of use and side effects (particularly for chlorhexidine) to support adherence.

Build the plan in this order

Step 1 — every patient correct brushing technique with a soft-bristled brush twice daily, daily interdental cleaning (floss, interdental brushes, or a water flosser for patients who will not floss), and a professional scaling appointment to remove any tartar/calculus — see Non-Pharmacologic Management.^[1]

Step 2 — bleeding/inflammation persists after 1-2 weeks of confirmed good technique, or short-term support is needed (for example, immediately post-scaling, or during a period of reduced hygiene such as with fixed orthodontic appliances) add chlorhexidine gluconate 0.12% oral rinse, 15 mL rinsed for 30 seconds twice daily after brushing, as part of a dentist- or prescriber-directed initial 3-month course.^[12] Counsel proactively on reversible tooth/tongue staining and taste alteration before the patient starts — this is the single most common reason for early, avoidable discontinuation.^[12]

Step 2, alternative — mild gingivitis, or ongoing maintenance once inflammation is controlled an OTC essential-oil rinse (thymol/eucalyptol/menthol-type) or a cetylpyridinium chloride rinse is a reasonable adjunct with genuine supporting evidence; comparative trials show essential-oil rinses with a modest edge over cetylpyridinium chloride at 3 and 6 months, though both meaningfully reduce plaque and gingivitis versus no rinse.^[13] Neither replaces brushing and flossing.

Suspected causative medication (phenytoin, cyclosporine, a calcium channel blocker) or pregnancy-associated gingivitis reinforce mechanical plaque control as first-line in both situations; for a suspected drug cause, raise a medication-review conversation with the prescriber rather than adjusting the drug independently (see Special Populations); for pregnancy-associated gingivitis, expect substantial improvement to continue through more frequent professional cleaning and largely resolve postpartum.^[9][8]

Suspected necrotizing gingivitis, periodontitis, or severe/refractory gingival hyperplasia refer to dentistry — see Red Flags and Referral. These are not managed with routine gingivitis self-care.

• Correct brushing technique — a soft-bristled (manual or power) toothbrush, angled toward the gumline, used for a full two minutes twice daily; this is the genuine foundation of treatment and the first thing to confirm before recommending anything else.^[1][2]
• Daily interdental cleaning — floss, interdental brushes, or a water flosser for patients who will not reliably floss; plaque between teeth is not reached by brushing alone and is a common site of persistent inflammation when this step is skipped.^[1]
• Regular professional dental cleaning (scaling) — the only way to remove calculus (mineralized plaque) once it has formed; this is core therapy, not an optional extra, since no amount of home brushing removes established tartar.^[1][2]
• Routine dental check-ups so early warning signs are caught and any progression toward periodontitis is identified before it becomes irreversible.^[1]
• Smoking cessation counselling — genuinely relevant here given smoking's role both in worsening gingival inflammation and in masking its most visible warning sign (bleeding).^[1][6]
• Glycemic optimization in patients with diabetes, as a genuine adjunct to (not a replacement for) mechanical plaque control, given the bidirectional relationship described in Risk Factors.^[7]
• For denture or orthodontic-appliance wearers: reinforce appliance-specific hygiene, since these are genuinely plaque-retentive and can perpetuate localized gingival inflammation despite otherwise reasonable technique.

Gingivitis before and after professional scaling, nine days apart — a visible illustration of how quickly mechanical plaque removal reverses gingival inflammation once the underlying biofilm and calculus are removed. (Onetimeuseaccount, CC0 1.0 Public Domain, Wikimedia Commons)

Pregnancy

Hormonal (pregnancy-associated) gingivitis affects an estimated 60% to 75% of pregnant women, driven by fluctuating estrogen and progesterone acting together with altered oral flora and a somewhat blunted local immune response; roughly half of women with pre-existing gingivitis notice significant worsening during pregnancy.^[8] Reinforce mechanical plaque control as first-line, and encourage additional professional cleanings during pregnancy since dental procedures including periodontal treatment are considered safe throughout pregnancy and are best timed to the second trimester when practical.^[8] Chlorhexidine in pregnancy reproduction/fertility studies in animals showed no evidence of fetal harm at doses far exceeding typical human exposure from rinsing, but controlled studies in pregnant women have not been conducted — the Health Canada product monograph directs that the benefits of use in pregnancy be weighed against any possible risk on an individual basis, in consultation with the dental/prescribing team.^[12] Expect substantial improvement to continue postpartum as hormone levels normalize, though persistent severe cases still warrant dental reassessment rather than being assumed to be self-limiting indefinitely.

Diabetes

Diabetes is one of only two true risk factors for periodontal disease (with smoking), and the relationship with gingival/periodontal inflammation is genuinely bidirectional.^[7] Reinforce that gingival/periodontal care is a genuine adjunct to glycemic management, not a substitute for it, and that current Canadian evidence supports periodontal maintenance visits no less often than every 3 months for patients with diabetes and any degree of gingival or periodontal inflammation, rather than the usual 6-12 month interval.^[7] Set expectations honestly: periodontal therapy produces a real but modest HbA1c benefit (roughly 0.26-0.65% at 3 months in the best available evidence), not a substitute for standard diabetes therapy.^[7]

Pediatrics

Gingivitis is reported by the American Dental Association to be very common among children.^[4] Supervise and reinforce brushing technique in young children, who often lack the fine motor skills for effective plaque removal on their own, and confirm interdental cleaning is actually happening rather than assumed. Fixed orthodontic appliances are a common, genuinely plaque-retentive risk factor in this age group and warrant reinforced technique specific to the appliance. Chlorhexidine's safety and efficacy in children has not been fully established — the Health Canada monograph directs that its use in children be weighed against possible risks on an individual, dentist-directed basis rather than recommended routinely.^[12]

Patients on phenytoin, cyclosporine, or a calcium channel blocker

Reinforce that meticulous plaque control measurably reduces the severity of drug-induced gingival hyperplasia even when the causative drug cannot be changed.^[9] Never suggest stopping or switching an anticonvulsant, immunosuppressant, or antihypertensive unilaterally for a gingival reason — raise it as a medication-review conversation with the prescriber, who can weigh whether an alternative agent within the same therapeutic class is appropriate for that patient. Severe, disfiguring, or functionally limiting overgrowth despite good plaque control may ultimately need surgical gingivectomy, which is a dental referral.^[9]

Smokers

Reduced visible bleeding on probing in smokers can mask the usual clinical warning sign of gingivitis, so a reassuring-looking exam in a smoker should not be taken at face value; combine visual assessment with a careful history and consider a slightly lower threshold for professional dental reassessment in this group.^[6]

Older adults

Consider cumulative xerogenic medication burden as a contributor to gingival health in this group — reduced salivary flow removes much of saliva's protective buffering and antibacterial effect, on top of any manual-dexterity barriers to effective brushing/flossing (for example, from arthritis).^[10] See this platform's Dry Mouth chapter for the medication-review approach to xerostomia itself.

• Reassess gingival colour, firmness, and bleeding at every follow-up; expect visible improvement within days to a week of consistent correct technique plus a completed professional cleaning, and substantial resolution within about 2-4 weeks.^[1]
• For patients using chlorhexidine gluconate 0.12% rinse: confirm the planned dental recall at the end of the initial 3-month course, at which point the dental team evaluates progress, removes any stain, and decides whether to discontinue (inflammation controlled) or continue for a further 3 months (inflammation still present) — this is not intended as an indefinite daily rinse.^[12]
• For pregnancy-associated gingivitis: confirm more frequent professional cleanings are actually happening, and specifically ask at postpartum follow-up whether gingival health has improved as expected — persistence should prompt dental reassessment rather than being assumed to be self-resolving indefinitely.^[8]
• For patients with diabetes: confirm periodontal maintenance visits are occurring at intervals no longer than 3 months, and reinforce that this is about periodontal health, not a mechanism for controlling HbA1c on its own.^[7]
• For patients on phenytoin, cyclosporine, or a calcium channel blocker: track gingival overgrowth severity at routine visits/refills, and flag any progression for the medication-review conversation described in Special Populations.^[9]
• Screen for the Red Flags and Referral findings (recession, mobility, purulence, refractory halitosis) at every follow-up, since these signal a shift from simple gingivitis to periodontitis that needs a different management pathway entirely.

1. No improvement after 2-4 weeks of reported good technique: verify technique directly rather than assuming it — many apparent non-responders have a correctable brushing/flossing technique problem, not a resistant disease process.^[1]
2. Persistent bleeding/inflammation despite verified good technique: confirm a professional scaling has actually been completed, since a toothbrush cannot remove established calculus; if scaling is done and inflammation persists, add or reassess a chlorhexidine rinse per Choose Initial Treatment.^[1][12]
3. Gingival hyperplasia not improving despite excellent plaque control in a patient on phenytoin, cyclosporine, or a calcium channel blocker: escalate the medication-review conversation with the prescriber, and refer to dentistry — surgical gingivectomy may ultimately be needed for overgrowth that does not respond to hygiene measures alone.^[9]
4. Pregnancy-associated gingivitis not settling despite reinforced hygiene and more frequent cleanings: continue supportive care through pregnancy — substantial improvement is expected postpartum — but reassess with dentistry if a case is unusually severe or painful, since pain is not typical of ordinary gingivitis at any stage.^[8]
5. Necrotizing gingivitis not responding to initial debridement, chlorhexidine rinse, and antibiotics, or any new systemic signs (spreading infection, high fever, marked malaise): escalate urgently and consider an underlying immunocompromising condition that may need its own workup.^[11]
6. Gingivitis that keeps recurring, or never fully resolves despite all of the above: refer for a full periodontal assessment to rule out unrecognized periodontitis, since attachment loss and true pocket depth can only be confirmed with a periodontal probe, which is outside pharmacy scope.^[3]

• Recommending a mouth rinse — chlorhexidine or an OTC alternative — as a substitute for brushing and flossing rather than as an adjunct to it.^[1]
• Recommending or allowing indefinite, unsupervised daily chlorhexidine use rather than the directed, time-limited course (an initial 3 months, then dental reassessment) it is actually approved for.^[12]
• Not warning patients in advance about chlorhexidine's staining and taste-alteration effects — a common, avoidable cause of early discontinuation when it comes as an unexpected surprise.^[12]
• Assuming any gum bleeding is "just gingivitis" without asking about anticoagulant/antiplatelet therapy, a bleeding disorder, or other systemic causes when the pattern does not fit routine plaque-induced disease.
• Missing medication-induced gingival hyperplasia because the medication list was not specifically reviewed for phenytoin, cyclosporine, or a calcium channel blocker.^[9]
• Suggesting a patient stop or switch phenytoin, cyclosporine, or a calcium channel blocker unilaterally rather than raising it with the prescriber.
• Treating necrotizing gingivitis as ordinary gingivitis and delaying dental referral — the punched-out papillae, grey pseudomembrane, and fetid breath pattern is a distinct, more urgent condition.^[11]
• Failing to recognize that any reported gum recession, tooth mobility, or pocketing means the case is no longer simple gingivitis and needs a formal periodontal assessment.^[3]
• Overlooking pregnancy or diabetes as contributing factors and missing a genuinely useful counselling opportunity in either group.
• Assuming a smoker's less-dramatic-looking bleeding on probing means healthier gums — nicotine-related vasoconstriction can mask the usual warning sign, so smokers deserve closer attention, not less.^[6]

How to use this table: Mouth-rinse doses are standard adult doses; confirm against the product's own labelling. Antibiotic and analgesic doses require patient-specific confirmation (renal/hepatic function, weight, allergy history, pregnancy status). Drug pricing is intentionally omitted. Select any linked drug name to open its complete Pharmasist Drug Database page.

Mouth Rinses

Adjuncts to mechanical plaque removal, not substitutes for it — see Non-Pharmacologic Management.

Necrotizing Gingivitis — Antibiotics and Analgesia

Used alongside dentist-performed debridement and a twice-daily 0.12% chlorhexidine rinse, not as stand-alone therapy. Reserve systemic antibiotics for fever, malaise, or other systemic involvement.

Representative Medications Causing Gingival Hyperplasia, by Class

Not a treatment table — these are causative medications flagged during a medication review, not agents to recommend. Never stop or switch any of these unilaterally; raise a medication-review conversation with the prescriber. See Risk Factors and Special Populations for the full discussion.